SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001624422-22-000028
Filing Date
2022-09-12
Accepted
2022-09-12 12:04:53
Documents
60
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 6-K eryp-20220630.htm   iXBRL 6-K 143192
2 EX-99.1 eryp-20220630_d2.htm   iXBRL EX-99.1 1251531
  Complete submission text file 0001624422-22-000028.txt   7069668

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eryp-20220630.xsd EX-101.SCH 55443
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eryp-20220630_cal.xml EX-101.CAL 86018
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eryp-20220630_def.xml EX-101.DEF 212096
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eryp-20220630_lab.xml EX-101.LAB 518422
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eryp-20220630_pre.xml EX-101.PRE 359531
54 EXTRACTED XBRL INSTANCE DOCUMENT eryp-20220630_htm.xml XML 1583775
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38281 | Film No.: 221238037
SIC: 2836 Biological Products, (No Diagnostic Substances)